Cooperative Agreement NU50CK000585

This $235,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support the development of infrastructure and documents to conduct a clinical trial evaluating the use of intravenous immunoglobulin (IVIG) to treat BK polyomavirus infections in pediatric kidney transplant recipients. The award will fund a planning grant to establish a prospective cohort of 120 pediatric kidney transplant recipients...

This federal Project Grant award of $799,952 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research at Northwestern University to investigate the role of the transcription factor HNF4A in the progression of chronic kidney disease (CKD) and associated complications such as inflammation, anemia, and bone/mineral disorders. The research aims...

This $550,000 Project Grant awarded by the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) supports the development of a remote monitoring system to reduce peritoneal dialysis (PD) infections. The project aims to create a medical device that can provide real-time, continuous monitoring of biomarkers in dialysate fluid to enable earlier detection and treatment of PD-associated infections. The key products and services to be delivered include: (1)...

This $843,457 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to evaluate the impact of an ABO-compatible kidney allocation policy on reducing organ non-use and improving access for disadvantaged kidney transplant candidates. The key objectives are to: (I) estimate the impact of ABO-compatible allocation on non-use rates and transplant outcomes, (II)...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through its Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $350,000 Project Grant to Katharos, Inc. on Jun 20, 2025. The grant supports the development of a novel extracorporeal technology, the "Phosfilter" device, which aims to enhance phosphate removal from the blood of hemodialysis patients and reduce the incidence of high phosphate-associated morbidity and...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through the Diabetes, Digestive, and Kidney Diseases Extramural Research Program (CFDA 93.847), awarded a $671,986 Project Grant to Rutgers, The State University of New Jersey, to conduct research aimed at strengthening the evidence-base for medication prescribing in older adults with chronic kidney disease (CKD). The key objectives of the 4-year project are to: 1) evaluate the effectiveness of renoprotective therapies...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $414,267 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The goal of this 5-year project, titled "Polycystic Kidney Disease In Vitro Center (PKD-INVENT)", is to expand and enable the preclinical-to-clinical research pathway for polycystic kidney disease (PKD) by generating products, services, and...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $314,355 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Angiotensin Therapeutics Inc., a biotechnology company located in Evanston, Illinois. The funding supports research to develop a soluble form of the enzyme Angiotensin Converting Enzyme 2 (ACE2) as a potential treatment for delayed graft function (DGF), a form of acute kidney injury that...

This federal Project Grant award of $644,770 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research grant program (CFDA 93.855), will support research to determine the impact of immunosuppression on the risk of post-transplant lymphoproliferative disorder (PTLD) and Epstein-Barr virus (EBV) infection in kidney transplant recipients receiving EBV-seropositive donor organs. The project aims to identify modifiable risk factors,...

This $171,639 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a "Multi-omic Investigation of Uremic Toxin Sources and Accumulation in Children with Kidney Failure" conducted by the Children's Hospital of Philadelphia (CHOP). The key objectives of this research project are to: 1) Characterize the contributions...